investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Pharmacogenetics of Phase II Drug Metabolizing Enzymes

Richard M Weinshilboum

2 Collaborator(s)

Funding source

National Institute of General Medical Sciences (NIH)

Liewei Wang

Mayo Clinic (Rochester)

Rochester, United States

Related projects

Barbara M Mueller

A Novel Plasminogen Receptor in Breast Cancer

Breast

Partha Roy

Profilin as a Target to Suppress Invasive Breast Cancer

Breast

Mauricio J Reginato

Role of Nutrient Sensor O-GlcNAc Transferase in Regulating Cancer

Breast

Christopher Benz

Mass Spectrometry to Decode PTM Patterns and Enhance the Biomarker Utility of ER

Breast

Richard G Pestell

Impact of Cyclin D1 Isoforms in Breast Cancer

Breast

Hui-Kuan Lin

Novel Posttranslational Modification in LKB1 Activation and Cancer Development

Breast

Jeffrey J Fredberg

Epithelial layer jamming in breast cancer cell migration

Breast

Gregory Longmore

Novel Small Molecule Inhibition of DDR2 to Prevent Breast Cancer Metastasis

Breast

Heide L Ford

Role of Six1 and the miR106b 25 Cluster in EMT and Tumor Progression

Breast